Uijeongbu, South Korea

Kyungchan Jeon

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Kobiolabs, Inc.. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyungchan Jeon. Retrieved from https://idiyas.com/inventor/kyungchan-jeon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kyungchan Jeon: Innovator in Alcoholic Liver Disease Research

Introduction

Kyungchan Jeon is a notable inventor based in Uijeongbu, South Korea. He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of alcoholic liver disease. With a total of 2 patents to his name, Jeon is recognized for his innovative approaches to healthcare.

Latest Patents

Kyungchan Jeon's latest patents focus on a composition for the diagnosis and treatment of alcoholic liver disease. His inventions utilize changes in the short-chain fatty acid-producing gut bacterial community. The first patent describes a microorganism that acts as a biomarker for alcoholic fatty liver disease. This invention includes a pharmaceutical composition aimed at preventing or treating the disease, as well as food and probiotics compositions designed to improve the condition.

Career Highlights

Jeon is currently associated with Kobiolabs, Inc., where he continues to advance his research. His work is pivotal in developing new therapeutic strategies for managing alcoholic liver disease.

Collaborations

Some of his notable coworkers include Woon Ki Kim and Boram Seo, who contribute to the collaborative efforts at Kobiolabs, Inc.

Conclusion

Kyungchan Jeon is a dedicated inventor whose work in the field of alcoholic liver disease is making a significant impact. His innovative patents and ongoing research hold promise for improving treatment options in this critical area of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…